APA (7th ed.) Citation

Cheng, H. H., Soleau, C., & Yu, E. Y. (2015). Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy. Journal of Hematology & Oncology, 8(1), 1. https://doi.org/10.1186/s13045-015-0149-x

Chicago Style (17th ed.) Citation

Cheng, Heather H., Colleen Soleau, and Evan Y. Yu. "Improved Disease Markers Suggest Dual Response in a Patient with Metastatic Castration Resistant Prostate Cancer and Chronic Lymphocytic Leukemia Following Active Cellular Immunotherapy." Journal of Hematology & Oncology 8, no. 1 (2015): 1. https://doi.org/10.1186/s13045-015-0149-x.

MLA (9th ed.) Citation

Cheng, Heather H., et al. "Improved Disease Markers Suggest Dual Response in a Patient with Metastatic Castration Resistant Prostate Cancer and Chronic Lymphocytic Leukemia Following Active Cellular Immunotherapy." Journal of Hematology & Oncology, vol. 8, no. 1, 2015, p. 1, https://doi.org/10.1186/s13045-015-0149-x.